Javier Grau

1.1k total citations
33 papers, 530 citations indexed

About

Javier Grau is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Javier Grau has authored 33 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Hematology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Javier Grau's work include Chronic Lymphocytic Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (13 papers) and Acute Myeloid Leukemia Research (10 papers). Javier Grau is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (13 papers) and Acute Myeloid Leukemia Research (10 papers). Javier Grau collaborates with scholars based in Spain, United States and Japan. Javier Grau's co-authors include Eric Lewis, David Rampe, Michael Murawsky, Josep‐María Ribera, Evarist Feliú, Jordi Juncà, Marc Sorigué, José‐Tomás Navarro, Fuensanta Millá and Albert Oriol and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Javier Grau

33 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Javier Grau Spain	12	181	173	163	160	128	33	530
Yassamin Feroz Zada Canada	10	190 1.0×	218 1.3×	52 0.3×	318 2.0×	80 0.6×	17	680
Sílvia Xargay‐Torrent Spain	15	395 2.2×	150 0.9×	144 0.9×	63 0.4×	31 0.2×	36	705
Aleksandra Butrym Poland	15	274 1.5×	112 0.6×	45 0.3×	241 1.5×	42 0.3×	58	645
Kavita Natarajan United States	5	174 1.0×	154 0.9×	23 0.1×	173 1.1×	32 0.3×	11	394
Paraskevi Roussou Greece	13	100 0.6×	152 0.9×	120 0.7×	83 0.5×	164 1.3×	21	528
Robert O. Bash United States	11	213 1.2×	81 0.5×	38 0.2×	109 0.7×	26 0.2×	15	690
Candice Jamois Switzerland	11	112 0.6×	91 0.5×	75 0.5×	39 0.2×	24 0.2×	30	374
Pierluigi Marradi Italy	12	74 0.4×	99 0.6×	71 0.4×	103 0.6×	9 0.1×	22	377
Linde M. Morsink Netherlands	11	95 0.5×	36 0.2×	39 0.2×	168 1.1×	21 0.2×	24	483
Lidia Usnarska‐Zubkiewicz Poland	11	98 0.5×	108 0.6×	55 0.3×	169 1.1×	49 0.4×	55	352

Countries citing papers authored by Javier Grau

Since Specialization

Citations

This map shows the geographic impact of Javier Grau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Grau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Grau more than expected).

Fields of papers citing papers by Javier Grau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Grau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Grau. The network helps show where Javier Grau may publish in the future.

Co-authorship network of co-authors of Javier Grau

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Grau. A scholar is included among the top collaborators of Javier Grau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Grau. Javier Grau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tapia, Gustavo, Marc Sorigué, Isabel Granada, et al.. (2023). HHV8 and EBV‐negative primary effusion‐based lymphoma: A case report of a new provisional entity and review of literature. SHILAP Revista de lepidopterología. 11(5). e7282–e7282. 1 indexed citations

Acha, Pamela, Laura Palomo, Francisco Fuster‐Tormo, et al.. (2021). Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach. Cancers. 13(4). 841–841. 6 indexed citations

Costa, Dolors, et al.. (2019). Conventional and molecular cytogenetic studies to characterize 2 complex variant Philadelphia translocations in patients with chronic myeloid leukemia. Oncology Letters. 17(6). 5705–5710. 6 indexed citations

Sorigué, Marc, et al.. (2018). Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma. Annals of Hematology. 97(9). 1633–1640. 12 indexed citations

Ribera, Josep‐María, Mireia Morgades, Isabel Granada, et al.. (2016). Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Leukemia & lymphoma. 58(1). 145–152. 6 indexed citations

Marcé, Sílvia, Montserrat Cortés, Lurdes Zamora, et al.. (2015). A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML). Experimental and Molecular Pathology. 99(1). 16–18. 9 indexed citations

Palomo, Laura, Blanca Xicoy, Olga García, et al.. (2015). Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases. American Journal of Hematology. 91(2). 185–192. 13 indexed citations

Marcé, Sílvia, Lurdes Zamora, Blanca Xicoy, et al.. (2013). Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitors. Medicina Clínica. 141(3). 95–99. 9 indexed citations

Valcárcel, David, Vera Ademà, Françesc Solé, et al.. (2013). Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome. Journal of Clinical Oncology. 31(7). 916–922. 48 indexed citations

10.

Oliveira, Ana Carla, Eva Domingo‐Doménech, Maite Encuentra, et al.. (2011). Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia. Leukemia & lymphoma. 52(3). 429–435. 4 indexed citations

11.

Navarro, José‐Tomás, Águeda Hernández, Jesús Rodríguez-Manzano, et al.. (2010). Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients. Medicina Clínica. 135(11). 485–490. 8 indexed citations

12.

Grau, Javier, Jordi Juncà, José Luís Mate, et al.. (2010). Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. Cancer Genetics and Cytogenetics. 203(2). 328–332. 14 indexed citations

13.

Santidrián, Antonio F., Ana M. Cosialls, Daniel Iglesias‐Serret, et al.. (2008). Multiplex ligation‐dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. British Journal of Haematology. 142(5). 793–801. 34 indexed citations

14.

Santidrián, Antonio F., Ana M. Cosialls, Daniel Iglesias‐Serret, et al.. (2007). Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukemia.. Molecular Cancer Therapeutics. 6. 9 indexed citations

15.

Perea, G, Albert Altés, Silvia Montoto, et al.. (2005). Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems. Annals of Oncology. 16(9). 1508–1513. 42 indexed citations

16.

Ribera, Josep‐María, José‐Tomás Navarro, Albert Oriol, et al.. (2002). Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease. AIDS. 16(14). 1973–1976. 24 indexed citations

17.

Batlle, Montserrat, Josep‐María Ribera, Albert Oriol, et al.. (2001). Neumonías en pacientes con leucemia linfática crónica. Estudio de 30 episodios. Medicina Clínica. 116(19). 738–740. 4 indexed citations

18.

Grau, Javier, Josep‐María Ribera, Gemma Ramírez, et al.. (2001). Resultados del tratamiento con 2-clorodesoxiadenosina en la histiocitosis de células de langerhans resistente o en recaída. Estudio de 9 pacientes. Medicina Clínica. 116(9). 339–342. 11 indexed citations

19.

Navarro, José‐Tomás, Josep‐María Ribera, Javier Grau, et al.. (2000). Enfermedad de Hodgkin en pacientes con infección por el virus de la inmunodeficiencia humana. Estudio de 15 casos. Medicina Clínica. 114(1). 19–21. 5 indexed citations

20.

Rampe, David, Michael Murawsky, Javier Grau, & Eric Lewis. (1998). The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG. Journal of Pharmacology and Experimental Therapeutics. 286(2). 788–793. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact